Coincidently, most recent reports have indicated that since a set of NMD targets encodes cell cycle inhibitory and pro-apoptotic factors, attenuation of NMD sensitizes cancer cells to chemotherapeutic agent-induced apoptosis [71,72]. Here, PLA1A is linked to cancer.